Glaukos (GKOS) Preferred Stock Liabilities (2014)

Glaukos (GKOS) posted quarterly Preferred Stock Liabilities of $157.4 million for Q4 2014.

Glaukos (GKOS) Preferred Stock Liabilities (2014) Analysis & Trends

Glaukos (GKOS) has reported Preferred Stock Liabilities for 1 consecutive years, with $157.4 million the latest figure, recorded in Q4 2014.

In Q4 2014, Preferred Stock Liabilities changed N/A year-over-year to $157.4 million; the TTM figure through Dec 2014 stood at $157.4 million (changed N/A YoY), while the FY2014 annual figure was $157.4 million, up 0.75% from the prior year.
Preferred Stock Liabilities held at $157.4 million in Q4 2014 per GKOS's latest filing.
Across five years, Preferred Stock Liabilities topped out at $157.4 million in Q4 2014 and bottomed at $157.4 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Abbott Laboratories	198.95 Bn	193.35 Bn	7.27 Bn	-
2	Stryker	128.10 Bn	124.63 Bn	4.50 Bn	-
3	Medtronic	118.91 Bn	109.69 Bn	6.41 Bn	-
4	Boston Scientific	73.43 Bn	72.89 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.91 Bn	47.66 Bn	1.35 Bn	-
6	Dexcom	34.52 Bn	32.58 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.94 Bn	31.83 Bn	2.18 Bn	-
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	-
9	Steris	23.14 Bn	22.66 Bn	684.20 Mn	-
10	Glaukos	11.08 Bn	10.96 Bn	151.59 Mn	-

Download Data

Date	Value
Dec 31, 2014	157.38 Mn